Picture of Bioqual logo

BIOQ Bioqual Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Annual income statement for Bioqual, fiscal year end - May 31st, USD millions except per share, conversion factor applied.

2018
May 31st
2019
May 31st
2020
May 31st
2021
May 31st
2022
May 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue35.939.546.457.766.2
Cost of Revenue
Gross Profit8.737.419.691413
Selling / General / Administrative Expenses
Total Operating Expenses30.635.94149.159.6
Operating Profit5.273.585.328.566.53
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes5.293.715.498.626.58
Provision for Income Taxes
Net Income After Taxes3.582.754.236.335.26
Net Income Before Extraordinary Items
Extraordinary Items
Net Income3.662.834.236.335.26
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income3.662.834.236.335.26
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS43.084.737.085.88
Dividends per Share

Or unlock with your email

Or unlock with your email